Hannover Re : Anticipation of a technical correction
Entry price | Target | Stop-loss | Potential |
---|
€119.5 |
€112 |
€123 |
+6.28% |
---|
The technical indicators point to a technical correction after the price rise of shares in Hannover Rückversicherung.
Summary● In view of fundamental criteria, the company is among low performers as far as mid or long-term investment strategy is concerned.
● The company has poor fundamentals for a short-term investment strategy.
Strengths● Historically, the company has been releasing figures that are above expectations.
● This company will be of major interest to investors in search of a high dividend stock.
● Over the past year, analysts have regularly revised upwards their sales forecast for the company.
● The tendency within the weekly time frame is positive above the technical support level at 107.5 EUR
Weaknesses● The stock is close to a major daily resistance at EUR 117.9, which should be gotten rid of so as to gain new appreciation potential.
● As estimated by analysts, this group is among those businesses with the lowest growth prospects.
● The three month average target prices set by analysts do not offer high potential in comparison with the current prices.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.